Proton pump inhibitors – are they truly safe?

Agnieszka Jankowska; Piotr Landowski; Anna Liberek; Barbara Kamińska

doi:10.5114/pg.2012.29878

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

3/2012
vol. 7

Send email

Copy url:

abstract:

Review paper

Proton pump inhibitors – are they truly safe?

Agnieszka Jankowska

,

Piotr Landowski

,

Anna Liberek

,

Barbara Kamińska

Prz Gastroenterol 2012; 7 (3): 133–137

DOI: https://doi.org/10.5114/pg.2012.29878

Online publish date: 2012/08/14

View full text Get citation

PlumX metrics:

The gastric enzyme hydrogen potassium ATPase, also known H⁺/K⁺-ATPase, is located in parietal cells of gastric mucosa. The enzyme plays an important role in gastric hydrochloric acid production. Proton pump inhibitors are a group of medicine indicated in the treatment of gastric and duodenal ulcers, eradication therapy associated with Helicobacter pylori infections and reflux oesophagitis as well as Zollinger Ellison syndrome. These drugs are characterized by only a few and not severe adverse effects, which might result in overuse. In this paper we consider possible consequences of long-term proton pump inhibitor therapy.

keywords:

Proton pump inhibitors – are they truly safe?

Agnieszka Jankowska , Piotr Landowski , Anna Liberek , Barbara Kamińska

proton pump inhibitors, overuse, adverse effects

Agnieszka Jankowska

,

Piotr Landowski

,

Anna Liberek

,

Barbara Kamińska